The ongoing partial federal government shutdown has meant staff furloughs and some delayed routine services by the FDA, excluding fee-funded activities. The medtech industry hasn’t been complaining about it yet, but time will tell, according to some experts.
“Agency operations continue to the extent permitted by law, such as activities necessary to address imminent threats to the safety of human life and activities funded by carryover user fee funds,” the federal watchdog said on its website. “… All our work is important, but only some of our work is permitted to continue during a lapse in funding.”
SOURCE – READ THE FULL ARTICLE AT:
https://www.medicaldesignandoutsourcing.com/how-is-the-partial-government-shutdown-affecting-fda/